Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolate Injection and Aspirin for Angina
NCT02694848Phase 4Unknown
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of salvianolate in angina pectoris (3 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Thromboelastogram parameters (R time, K time, alpha angle, MA, CI, TPI) at 10 days. Status: unknown.
02
Drugs
salvianolate
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT02694848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02694848.